Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism
- PMID: 12223537
- PMCID: PMC6758069
- DOI: 10.1523/JNEUROSCI.22-18-07850.2002
Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism
Abstract
Previous physiological studies have revealed changes in firing rates and synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease. Several primate and human studies have demonstrated that dopamine replacement therapy (DRT) reverses the changes in the pallidal firing rates; however, the effects of DRT on pallidal synchronization have never been explored. To do so, we recorded the simultaneous activity of pallidal neurons of a vervet monkey before and after induction of severe parkinsonism by systemic MPTP treatment. We subsequently recorded the pallidal activity before and after daily administration of oral DRT. We extended the time scale of our correlation studies to +/-5 sec to allow detection of long-duration synchronized neuronal activity. After MPTP treatment, firing rates decreased in the external segment of the globus pallidus (GP(e)) and increased in the internal segment (GP(i)). A reversal of these rate changes occurred during the "on" periods of DRT. The percentage of correlated pairs increased from 16.7% in the normal state to 46.9% after MPTP treatment and was restored to nearly normal values (25% correlated pairs) under the influence of DRT. These changes in rate and correlation were observed at both the population level and at the level of units recorded continuously before, during, and after the clinical transition from "off" to "on" periods. We conclude that changes in both pallidal discharge rates and synchronization are correlated with the clinical manifestations of parkinsonism and its pharmacological treatment.
Figures
Similar articles
-
Dopamine replacement therapy does not restore the full spectrum of normal pallidal activity in the 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine primate model of Parkinsonism.J Neurosci. 2006 Aug 2;26(31):8101-14. doi: 10.1523/JNEUROSCI.5140-05.2006. J Neurosci. 2006. PMID: 16885224 Free PMC article.
-
Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism.J Neurosci. 2000 Nov 15;20(22):8559-71. doi: 10.1523/JNEUROSCI.20-22-08559.2000. J Neurosci. 2000. PMID: 11069964 Free PMC article.
-
Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease.J Neurosci. 2002 Jun 1;22(11):4639-53. doi: 10.1523/JNEUROSCI.22-11-04639.2002. J Neurosci. 2002. PMID: 12040070 Free PMC article.
-
Experimental parkinsonism in primates.Stereotact Funct Neurosurg. 2001;77(1-4):91-7. doi: 10.1159/000064603. Stereotact Funct Neurosurg. 2001. PMID: 12378063 Review.
-
The MPTP-treated primate as a model of motor complications in PD: primate model of motor complications.Neurology. 2003 Sep 23;61(6 Suppl 3):S4-11. doi: 10.1212/wnl.61.6_suppl_3.s4. Neurology. 2003. PMID: 14504374 Review.
Cited by
-
Dysregulation of external globus pallidus-subthalamic nucleus network dynamics in parkinsonian mice during cortical slow-wave activity and activation.J Physiol. 2020 May;598(10):1897-1927. doi: 10.1113/JP279232. Epub 2020 Apr 23. J Physiol. 2020. PMID: 32112413 Free PMC article.
-
What is the true discharge rate and pattern of the striatal projection neurons in Parkinson's disease and Dystonia?Elife. 2020 Aug 19;9:e57445. doi: 10.7554/eLife.57445. Elife. 2020. PMID: 32812870 Free PMC article.
-
The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian rats.Brain. 2011 Nov;134(Pt 11):3276-89. doi: 10.1093/brain/awr226. Epub 2011 Sep 12. Brain. 2011. PMID: 21911417 Free PMC article.
-
Dispersed activity during passive movement in the globus pallidus of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated primate.PLoS One. 2011 Jan 18;6(1):e16293. doi: 10.1371/journal.pone.0016293. PLoS One. 2011. PMID: 21267415 Free PMC article.
-
Revisiting the "Paradox of Stereotaxic Surgery": Insights Into Basal Ganglia-Thalamic Interactions.Front Syst Neurosci. 2021 Aug 27;15:725876. doi: 10.3389/fnsys.2021.725876. eCollection 2021. Front Syst Neurosci. 2021. PMID: 34512279 Free PMC article. Review.
References
-
- Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989;12:366–375. - PubMed
-
- Bar-Gad I, Ritov Y, Bergman H. Failure in identification of overlapping spikes from multiple neuron activity causes artificial correlations. J Neurosci Methods. 2001;107:1–13. - PubMed
-
- Bedard PJ, Di Paolo T, Falardeau P, Boucher R. Chronic treatment with l-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys: correlation with [3H]spiperone binding. Brain Res. 1986;379:294–299. - PubMed
-
- Ben Shaul Y, Bergman H, Ritov Y, Abeles M. Trial to trial variability in either stimulus or action causes apparent correlation and synchrony in neuronal activity. J Neurosci Methods. 2001;111:99–110. - PubMed
-
- Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol. 1994;72:507–520. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous